In Vitro Modeling as a Tool for Testing Therapeutics for Spinal Muscular Atrophy and IGHMBP2-Related Disorders.

MLA

Sierra-Delgado, Julieth Andrea, et al. “In Vitro Modeling as a Tool for Testing Therapeutics for Spinal Muscular Atrophy and IGHMBP2-Related Disorders.” Biology (2079-7737), vol. 12, no. 6, June 2023, p. 867. EBSCOhost, https://doi.org/10.3390/biology12060867.

APA

Sierra-Delgado, J. A., Sinha-Ray, S., Kaleem, A., Ganjibakhsh, M., Parvate, M., Powers, S., Zhang, X., Likhite, S., & Meyer, K. (2023). In Vitro Modeling as a Tool for Testing Therapeutics for Spinal Muscular Atrophy and IGHMBP2-Related Disorders. Biology (2079-7737), 12(6), 867. https://doi.org/10.3390/biology12060867

Chicago

Sierra-Delgado, Julieth Andrea, Shrestha Sinha-Ray, Abuzar Kaleem, Meysam Ganjibakhsh, Mohini Parvate, Samantha Powers, Xiaojin Zhang, Shibi Likhite, and Kathrin Meyer. 2023. “In Vitro Modeling as a Tool for Testing Therapeutics for Spinal Muscular Atrophy and IGHMBP2-Related Disorders.” Biology (2079-7737) 12 (6): 867. doi:10.3390/biology12060867.